Histological outcomes of EGF and bFGF primed-mesenchymal stem cells used in the treatment of an r6/2 rodent model of Huntington’s disease

Research output: Other contribution

Fingerprint

Dive into the research topics of 'Histological outcomes of EGF and bFGF primed-mesenchymal stem cells used in the treatment of an r6/2 rodent model of Huntington’s disease'. Together they form a unique fingerprint.

Medicine & Life Sciences